• Return to Headlines

Relatively Good Performance Detected in Shares of BioMimetic Therapeutics in the Pharmaceuticals Industry (BMTI, MDCO, NKTR, LLY, PFE)

Written on Wed, 07/28/2010 - 5:27am
By Chip Brian

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.
BioMimetic Therapeutics (NASDAQ:BMTI) ranks first with a gain of 5.13%; Medicines Co (NASDAQ:MDCO) ranks second with a gain of 2.71%; and Nektar Therapeutics (NASDAQ:NKTR) ranks third with a gain of 1.92%.
Eli Lilly (NYSE:LLY) follows with a gain of 1.86% and Pfizer (NYSE:PFE) rounds out the top five with a gain of 1.66%.
SmarTrend is bearish on shares of BMTI and our subscribers were alerted to Sell on May 21, 2010 at $12.20. The stock has fallen 27.7% since the alert was issued.

Keywords: biomimetic therapeutics relative performance

Ticker(s): BMTI MDCO NKTR LLY PFE

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.